Efficacy and safety of Janus kinase inhibitors in the treatment of psoriasis and psoriatic arthritis: An analysis of evidence from 2014 to 2022

Efficacy and safety of Janus kinase inhibitors in the treatment of psoriasis and psoriatic arthritis: An analysis of evidence from 2014 to 2022

Background: The efficacy and safety of Janus kinase (JAK) inhibitors as novel therapeutic agents for psoriasis (PSO) and psoriatic arthritis (PsA) have not yet been systematically evaluated. Methods: Randomized controlled studies (RCTs) assessing JAK inhibitors to treat PSO or PsA published before S...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiao Wang, Tian Ma, Xiaoying Sun, Liu Liu, Seokgyeong Hong, Huijung Cha, Miao Zhang, Jiale Chen, Naixuan Lin, Bin Li, Xin Li
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Heliyon
Subjects:
Janus kinase (JAK) inhibitors
Psoriasis (PSO)
Psoriatic arthritis (PsA)
Randomized controlled study
Meta-analysis
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844025004645
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items